This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Improving the quality of older people’s care in EDs
Read more
Airway management in the obese
Read more
Cost-effectiveness of remote ischaemic conditioning
Read more
TAVI: value for the patient and the hospital
Read more
NICE sets out draft recommendations for Repatha® in Final Appraisal Determination
Read more
Foreword
Read more
Reducing cardiovascular disease by 2025
Read more
UMC Utrecht is first hospital to expand diagnostic capabilities with Philips IQon Spectral CT System
Read more
Olympus and King’s College Hospital to deliver Britain’s largest 3D surgical endoscopy installation
Read more
New European policy recommendations on cytotoxic drugs
Read more
Daclizumab demonstrates significant improvements in cognition compared to interferon beta-1a IM
Read more
NICE gives green light to new drug set to benefit 100,000 people with common heart condition
Read more
Patients with advanced mCRC have a new treatment option as LONSURF® receives EU approval
Read more
Neurological expertise crucial to deal with devastating Zika consequences
Read more
Boston Scientific announces CE mark for MRI labelling of EMBLEM™ S-ICD Systems
Read more
EADV launches Global Call to Action to protect outdoor workers from skin cancer caused by the sun
Read more
TECFIDERA® data highlights benefit of early treatment in relapsing-remitting multiple sclerosis
Read more
Page 145 of 200
« First
«
...
10
20
30
...
143
144
145
146
147
...
150
160
170
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: